EICHOR
● Terminated
Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis
Condition: Prevention of Esophageal Varices · NASH - Nonalcoholic Steatohepatitis · Cirrhosis · Sponsor: Galectin Therapeutics Inc.
About this study
This seamless, adaptive, two-stage, Phase 2b/3, randomized, double-blind, multicenter, parallel-groups, placebo-controlled study will assess the efficacy, safety, and tolerability of belapectin compared with placebo in patients with nonalcoholic steatohepatitis (NASH) cirrhosis and clinical signs of portal hypertension but without esophageal varices at baseline.
This description comes directly from the study's public registry record.
Talk to the study team
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
Locations (156)
| University of Alabama at Birmingham | Birmingham, Alabama, United States | — |
| Digestive Health Specialists | Dothan, Alabama, United States | — |
| The Institute for Liver Health | Chandler, Arizona, United States | — |
| Arizona Liver Health - Glendale | Glendale, Arizona, United States | — |
| Institute for Liver Health - Tucson | Tucson, Arizona, United States | — |
| Liver Wellness Center - Little Rock | Little Rock, Arkansas, United States | — |
| Hope Clinical Research, Inc. | Canoga Park, California, United States | — |
| Southern California GI & Liver Centers | Coronado, California, United States | — |
| University of California San Diego Medical Center -La Jolla Multi-Specialty Clinics- Perlman Offices | La Jolla, California, United States | — |
| Om Research LLC | Lancaster, California, United States | — |
| Cedars-Sinai Medical Center | Los Angeles, California, United States | — |
| inSite Digestive Health Care - Orange | Orange, California, United States | — |
+ 144 more locations — full list on the registry record.
Follow this study
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04365868